Company
United StatesPublic company, NYSE: CAHCardinal Health (NYSE: CAH), Riverview, FL – FDA Inspections
Inspection records and compliance data for Cardinal Health in Riverview, Florida. 1 FDA inspection on record, 1 Form 483, last inspected January 25, 2017. Publicly traded as NYSE: CAH.
Company Profile
This profile covers Cardinal Health based in Riverview, Florida, United States.
FDA Inspection History
- FDA inspections
- 1
- OAI
- 0
- VAI
- 0
- NAI
- 1
- Form 483s
- 1
- Warning letters
- 0
Inspected January 25, 2017.
Most cited issue areas
- Design Validation - Risk analysis not performed/inadequate1 inspection
- Lack of or inadequate procedures1 inspection
- Lack of or inadequate process validation1 inspection
FDA inspections (1)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| January 25, 2017 | NAI | Medical Devices & Rad Health · Postmarket Assurance: Devices | 1001711 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Cardinal Health
Stock ticker
CAH
Exchange
NYSE
Share price
$269.30
Market cap
$62.4B
Price as of
November 6, 2026
FEI Number
3011200334
Address
8322 Eagle Palm Dr, Riverview, Florida 33578, United States
Country
United States
ID: 3729ce08-e7b7-4901-9a44-742408272c9f